These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17069648)

  • 1. The effects of continuous venovenous hemofiltration on coagulation activation.
    Bouman CS; de Pont AC; Meijers JC; Bakhtiari K; Roem D; Zeerleder S; Wolbink G; Korevaar JC; Levi M; de Jonge E
    Crit Care; 2006; 10(5):R150. PubMed ID: 17069648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration.
    Cardigan RA; McGloin H; Mackie IJ; Machin SJ; Singer M
    Kidney Int; 1999 Apr; 55(4):1568-74. PubMed ID: 10201024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous venovenous haemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic coagulation pathways.
    Salmon J; Cardigan R; Mackie I; Cohen SL; Machin S; Singer M
    Intensive Care Med; 1997 Jan; 23(1):38-43. PubMed ID: 9037638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation, Fibrinolysis and Inhibitors in Failing Filters during Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: Effect of Anticoagulation Modalities.
    Schilder L; Nurmohamed SA; ter Wee PM; Paauw NJ; Girbes AR; Beishuizen A; Beelen RH; Groeneveld AB
    Blood Purif; 2015; 39(4):297-305. PubMed ID: 25966765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates.
    Oudemans-van Straaten HM; van Schilfgaarde M; Molenaar PJ; Wester JP; Leyte A
    Crit Care; 2009; 13(6):R193. PubMed ID: 19958532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predilution versus postdilution during continuous venovenous hemofiltration: a comparison of circuit thrombogenesis.
    de Pont AC; Bouman CS; Bakhtiari K; Schaap MC; Nieuwland R; Sturk A; Hutten BA; de Jonge E; Vroom MB; Meijers JC; Büller HR
    ASAIO J; 2006; 52(4):416-22. PubMed ID: 16883122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostatic alterations during continuous venovenous hemofiltration in acute renal failure.
    Stefanidis I; Hägel J; Frank D; Maurin N
    Clin Nephrol; 1996 Sep; 46(3):199-205. PubMed ID: 8879856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
    Tiranathanagul K; Jearnsujitwimol O; Susantitaphong P; Kijkriengkraikul N; Leelahavanichkul A; Srisawat N; Praditpornsilpa K; Eiam-Ong S
    Ther Apher Dial; 2011 Dec; 15(6):556-64. PubMed ID: 22107692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostasis during normal pregnancy and puerperium.
    Hellgren M
    Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood coagulation activation and fibrinolysis during a downhill marathon run.
    Sumann G; Fries D; Griesmacher A; Falkensammer G; Klingler A; Koller A; Streif W; Greie S; Schobersberger B; Schobersberger W
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):435-40. PubMed ID: 17581317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor/factor VIIa pathway mediates coagulation activation in induced-heat stroke in the baboon.
    Bouchama A; Al-Mohanna F; Assad L; Baturcam E; Eldali A; Owaidah T; Dehbi M
    Crit Care Med; 2012 Apr; 40(4):1229-36. PubMed ID: 22080642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of different types of resuscitation fluids on coagulation and continuous venovenous hemofiltration hemocompatibility in a porcine model.
    Bedarf JR; Grosch-Ott S; Russ M; Wagner JJ; Hiebl B; Kirschfink M; Unger JK
    Ther Apher Dial; 2013 Oct; 17(5):510-23. PubMed ID: 24107280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of fibrinolytic pathways is associated with duration of supraceliac aortic cross-clamping.
    Haithcock BE; Shepard AD; Raman SB; Conrad MF; Pandurangi K; Fanous NH
    J Vasc Surg; 2004 Aug; 40(2):325-33. PubMed ID: 15297829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations.
    te Velthuis H; Baufreton C; Jansen PG; Thijs CM; Hack CE; Sturk A; Wildevuur CR; Loisance DY
    J Thorac Cardiovasc Surg; 1997 Jul; 114(1):117-22. PubMed ID: 9240301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of anticoagulation regimens on handling of interleukin-6 and -8 during continuous venovenous hemofiltration in critically ill patients with acute kidney injury.
    Schilder L; Nurmohamed SA; ter Wee PM; Girbes AR; Beishuizen A; Paauw NJ; Beelen RH; Groeneveld AB
    Cytokine; 2012 Dec; 60(3):601-7. PubMed ID: 23006672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
    Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?
    Dietrich W
    J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S50-7. PubMed ID: 8938284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemostatic changes in systemic inflammatory response syndrome during continuous renal replacement therapy.
    García-Fernández N; Lavilla FJ; Rocha E; Purroy A
    J Nephrol; 2000; 13(4):282-9. PubMed ID: 10946808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.